LifePoint Health, Inc. (NASDAQ:LPNT) Chairman William F. Carpenter III sold 17,653 shares of the firm’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $65.06, for a total value of $1,148,504.18. Following the completion of the sale, the chairman now directly owns 439,841 shares in the company, valued at $28,616,055.46. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

LifePoint Health, Inc. (NASDAQ LPNT) opened at 65.50 on Friday. LifePoint Health, Inc. has a 1-year low of $50.60 and a 1-year high of $70.95. The stock has a 50 day moving average price of $64.84 and a 200 day moving average price of $62.76. The firm has a market capitalization of $2.64 billion, a price-to-earnings ratio of 17.28 and a beta of 0.88.

LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Friday, April 28th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.06. LifePoint Health had a return on equity of 7.06% and a net margin of 2.26%. The firm had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the company posted $0.85 earnings per share. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. Analysts predict that LifePoint Health, Inc. will post $4.19 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/07/21/insider-selling-lifepoint-health-inc-lpnt-chairman-sells-17653-shares-of-stock.html.

A number of analysts have issued reports on LPNT shares. BidaskClub raised LifePoint Health from a “sell” rating to a “hold” rating in a research note on Wednesday, June 14th. Barclays PLC raised their price target on LifePoint Health from $58.00 to $60.00 and gave the stock an “equal weight” rating in a research note on Monday, May 1st. Zacks Investment Research raised LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 price target on the stock in a research note on Thursday, July 13th. Morgan Stanley started coverage on LifePoint Health in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 price target on the stock. Finally, Mizuho raised their price target on LifePoint Health from $57.00 to $62.00 and gave the stock a “neutral” rating in a research note on Monday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and six have issued a buy rating to the stock. LifePoint Health has a consensus rating of “Hold” and a consensus price target of $66.08.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Renaissance Technologies LLC purchased a new position in shares of LifePoint Health during the fourth quarter worth approximately $1,717,000. Two Sigma Investments LP bought a new stake in LifePoint Health during the fourth quarter valued at about $910,000. Thrivent Financial for Lutherans increased its stake in LifePoint Health by 3.6% in the fourth quarter. Thrivent Financial for Lutherans now owns 6,930 shares of the company’s stock valued at $394,000 after buying an additional 240 shares during the period. Numeric Investors LLC bought a new stake in LifePoint Health during the fourth quarter valued at about $335,000. Finally, Norges Bank bought a new stake in LifePoint Health during the fourth quarter valued at about $19,865,000. Hedge funds and other institutional investors own 99.54% of the company’s stock.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Insider Buying and Selling by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.